IN anaesthetized, paralysed, ventilated pigs the ability of inhaled nitric oxide (80 ppm in 02) to reduce the haemodynamic and respiratory effects of endothelin-1 administration (200 pmol/kg, i.v.) was evaluated. The mechanical properties of the respiratory system were evaluated by the rapid airway occlusion technique. The overall respiratory resistance, the interrupter resistance and the additional resistance that reflects the viscoelastic properties of tissues and the inequality of the time constant within the system were also evaluated. The results show that inhaled nitric oxide can act as a selective pulmonary vasodilator and as a bronchodilator to counteract the vasoconstrictor and bronchoconstrictor activity of endothelin-1. In the pig, nitric oxide inhaled at 80 ppm for 6 mitt reduced the changes in respiratory-, interrupter-and additional resistance due to endothelin-1 administration without significantly changing the static and dynamic elastance of the respiratory system.
Introduction
There have been reports concerning mediators released from endothelium which modulate the contraction of the vascular and non-vascular smooth muscles. These mediators include some arachidonic acid metabolites (PgI2, TXA,), the vasoconstrictor peptides (endothelin) and endothelium-dependent releasing factor (EDRF), recently identified as nitric oxide (NO) . >7 Experiments performed in vivo in the guinea-pig or in vitro on isolated guinea-pig and rabbit airway segments showed that endothelin-1 (ET-1), a peptide of endothelin family, induces bronchoconstriction, s-l The localization of ET-l-like immunoreactivity in the airway epithelium of rats and mice, associated with the activity of the peptide on the tracheobronchial tree indicate that ET-1 has a role in modulation of bronchial tone. ,*" Nitric oxide, the new potent endothelial vasodilator factor, recently discovered by Furchgott and Zadawski, inhibits the contraction in vitro of tracheal smooth muscles from man and the guinea-pig, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] but has no effect on canine bronchial smooth muscle. 16 Even though its effects on bronchial smooth muscles differ for different muscles, nitric oxide is considered to be a mediator of a nonadrenergic noncholinergic (NANC) system regulating bronchial tone. 3a5 It has been shown in animal and human studies that inhalation of NO attenuates the hypoxic pulmonary vasoconstriction response and tromboxane mediated pulmonary vascular contraction. Therefore, an imbalance of the ratio of ET-1 to NO could contribute to the appearance of ( Fig. 1 ). 17, 18 demonstrated that inhalation of NO at small doses (5-80 ppm) reversed hypoxic pulmonary vasoconstriction, without causing systemic vasodilatation, and attenuated thromboxane-mediated pulmonary vascular contraction. Consequently, it has been suggested that inhaled NO might be an important tool for reducing pulmonary hypertension in severe cardiac pulmonary diseases. 21 As in previous studies, 7a8 the present results show that in the pig, too, inhaled NO has a selective vasodilator activity in the lung, without affecting systemic pressure. This local response is probably due to its rapid reaction with haemoglobin to form methaemoglobin or to its conversion into nitrites and nitrates. 4, 22, 23 The rapid inactivation prevents the systemic vascular relaxing effect of NO, without altering the systemic vasoconstrictor activity of endothelin-1.
Mediators of Inflammation. Vo13. 1994 The absence of significant changes in methaemoglobin, in our pigs, suggests that NO has modest toxicity when inhaled at low concentrations.
As found by Frostell et al. 17 
